Neurocrine Biosciences reports publication of new research establishing clinically meaningful improvement threshold for TDIS

Precision Biosciences initiates patient enrollment in PBGENE-DMD clinical study

Immunome submits FDA application for varegacestat following strong Phase 3 results

HUTCHMED secures priority review for sovleplenib NDA in China

Chiesi Group to acquire KalVista Pharmaceuticals for USD1.9bn in rare disease expansion strategy

Circio partners with USC to advance non-viral RNA delivery technologies

Cirius Therapeutics introduces gestational diabetes initiative

Vanda Pharmaceuticals reports publication of imsidolimab phase III findings in NEJM Evidence

Insilico's Rentosertib inhalation solution receives IND clearance to enter direct-to-lung clinical study

GSK hepatitis B therapy bepirovirsen gains FDA priority review and breakthrough designation

Boehringer Ingelheim's survodutide phase 3 data show significant weight loss in obesity trial

Johnson & Johnson IMAAVY (nipocalimab-aahu) granted FDA Priority Review as potential treatment for wAIHA

Lilly agrees to acquire Ajax Therapeutics

Novartis secures European approval for remibrutinib in chronic spontaneous urticaria

GSK secures US and EU fast-track designations for efimosfermin in MASH